ReviewJournal of clinical & translational endocrinology2025

SGLT2 inhibitor therapy in overweight and obese patients with cystic fibrosis-related diabetes: Case series.

Ammar Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.